Related Experiment Video
Updated: Feb 16, 2026

07:17
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
12.6K
CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer
Alex D Michaels1, Timothy E Newhook1, Sara J Adair1
1Department of Surgery, University of Virginia Health System, Charlottesville, Virginia.
Summary
Liver macrophages suppress pancreatic cancer liver metastasis. Blocking the CD47 "don't eat me" signal enhances macrophage clearance of pancreatic ductal adenocarcinoma cells, prolonging survival in mice.
Area of Science:
- Immunology
- Oncology
- Cancer Metastasis
Background:
- Pancreatic ductal adenocarcinoma (PDAC) patients face poor survival due to frequent liver recurrence after surgery and chemotherapy.
- Liver macrophages play a critical role in the progression of PDAC micrometastases.
- Identifying effective adjuvant therapies is crucial to improve patient outcomes.
Purpose of the Study:
- To investigate the role of liver macrophages in PDAC liver micrometastasis progression.
- To identify potential adjuvant treatment strategies targeting liver macrophages to prolong survival.
Main Methods:
- Utilized a murine splenic injection model of hepatic micrometastatic PDAC with patient-derived tumors.
- Assessed liver macrophage impact by depletion (liposomal clodronate) and using different mouse strains (nude vs. NOD-scid-gamma).
- Measured CD47 expression and performed in vitro/in vivo engulfment assays with CD47-blocking antibodies.
Main Results:
- Liver macrophages were found to suppress PDAC micrometastasis progression.
- CD47 expression varied among PDAC cell lines; blocking CD47 enhanced macrophage-mediated tumor cell clearance.
- Treatment with CD47-blocking antibodies increased time-to-progression and prolonged survival in mice.
Conclusions:
- Liver macrophages act as a barrier to PDAC liver metastasis.
- Targeting CD47 with blocking antibodies represents a promising adjuvant immunotherapy strategy.
- Anti-CD47 antibody therapy could significantly improve outcomes for patients with resected PDAC.
Related Concept Videos
Neuromuscular Junction And Blockade
5.1K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.1K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Pancreatic Juice and Secretion
3.1K
Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
3.1K
Acute Pancreatitis I: Introduction
1.3K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.3K
Chronic Pancreatitis I: Introduction
751
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
751
Chronic Pancreatitis II: Collaborative Care
384
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
384

